Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IL17A | Q16552 | 7/20 | 0.35 |
| ▸ | MAP3K12 | Q12852 | 3/20 | 0.33 |
| ▸ | DLK1 | P80370 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | GSK3B | P49841 | 2/20 | 0.32 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.31 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.31 |
| ▸ | BTK | Q06187 | 2/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30953419 | 0.92 | IL17A (0.34) | IL17AMAP3K12DLK1MAPTGSK3B | |
| SCHEMBL30953344 | 0.91 | IL17A (0.34) | IL17AMAPTGSK3BABCB11CHRM2 | |
| SCHEMBL30953460 | 0.85 | AAK1 (0.37) | IL17AMAPTGSK3BABCB11CHRM2 | |
| SCHEMBL30953013 | 0.85 | IL17A (0.46) | IL17AABCB11CHRM2SLCO1B1NR3C2 | |
| SCHEMBL30953516 | 0.83 | IL17A (0.41) | IL17AABCB11CHRM2SLCO1B1BTK | |
| SCHEMBL30953215 | 0.83 | MAPT (0.34) | IL17AMAP3K12DLK1MAPTGSK3B | |
| SCHEMBL30953141 | 0.80 | IL17A (0.34) | IL17A | |
| SCHEMBL30953094 | 0.79 | IL17A (0.35) | IL17ANR3C2 | |
| SCHEMBL30953104 | 0.79 | IL17A (0.38) | IL17ANR3C2 | |
| SCHEMBL30953075 | 0.78 | IL17A (0.38) | IL17AGSK3BABCB11CHRM2SLCO1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630115-A1 | THERAPEUTIC COMPOUNDS | Sanofi (FR) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024121427-A1 | THERAPEUTIC COMPOUNDS | SANOFI (FR) | 2024-06-13 | — | — | WO | disclosed |